Metabolic syndrome has been implicated in the development of prostate cancer, but there have been no published data on whether it affects the effectiveness of androgen deprivation therapy (ADT).
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, metabolic syndrome, outcome, survival | Leave a Comment »

Search for new and
ongoing trials on the
CTAG PCa web site
